Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Spasticity is a motor disorder that can affect the lower limbs in up to 75% patients with
cerebral palsy, having a significantly effect on their mobility and quality of life. There is
much controversy about what is the most appropriate treatment of spasticity The objective of
the present study is to evaluate the effects of radial extracorporeal shock wave therapy
(rESWT) compared to treatment with botulinum toxin to improve spasticity in patients with
cerebral palsy
The number needed of patients is 70 (35 per group). Leaving a period of washout between one
therapy and the other
Phase:
Phase 1
Details
Lead Sponsor:
Xavi Vidal Novellas
Collaborator:
Cerebral Palsy Association
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA